Compare Marsh & McLennan Companies, Inc. (MRSH) vs D Wave Quantum Inc (QBTS) Price & Performance

Marsh & McLennan (MRSH) trades at $180.52, down 2.81% on the day, with a bullish technical signal despite recent weakness. The stock shows strong fundamentals, including consistent earnings beats, a 14.24% net income margin, and robust cash flow. Recent news highlights growth in healthcare consulting and cyber risk services, supporting revenue expansion.

Outlook remains positive with a consensus price target of $208.63, offering 15% upside. Risks include economic sensitivity and debt levels, but analyst sentiment leans bullish with 30% buy ratings. The stock presents a growth opportunity in professional services, backed by solid financials and strategic initiatives.

QBTS trades at $17.67, up 6.57% in the last session, but remains down 33% year-to-date. The stock shows a bearish technical trend with key support at $17 and resistance at $18. Fundamentally, the company reported a net loss of $355.06 million on $24.59 million in revenue for 2025, with a negative net income margin of -2,001.59% in 2026. Recent positive news includes a $100 million funding agreement with the U.S. Department of Commerce under the CHIPS Act, announced on September 8, 2026.

Despite unanimous analyst buy ratings and a $37.00 consensus price target, significant execution risks persist. High cash burn, negative profitability, and ongoing SEC investigations pose challenges. The stock's upside depends on successful commercialization of quantum technology and effective use of government funding, but near-term volatility is expected amid sector-wide pressures and macroeconomic uncertainty.